EcoDrugPlus

Ensembl ID : ENSCHYG00000026214
Gene Symbol: -
Cross references: -
160 Possible Orthologues:

Ensembl ID : ENSCHYG00000026685
Gene Symbol: -
Cross references: -
184 Possible Orthologues:

Ensembl ID : ENSCHYG00000026761
Gene Symbol: -
Cross references: -
208 Possible Orthologues:

Ensembl ID : ENSCHYG00000026660
Gene Symbol: -
Cross references: -
198 Possible Orthologues:

Ensembl ID : ENSCHYG00000026476
Gene Symbol: -
Cross references: -
222 Possible Orthologues:

Ensembl ID : ENSCHYG00000025964
Gene Symbol: -
Cross references: -
272 Possible Orthologues:

Ensembl ID : ENSCHYG00000025882
Gene Symbol: -
Cross references: -
297 Possible Orthologues:

Ensembl ID : ENSCHYG00000021163
Gene Symbol: -
Cross references: -
218 Possible Orthologues:

Ensembl ID : ENSCHYG00000015676
Gene Symbol: -
Cross references: -
190 Possible Orthologues:

Ensembl ID : ENSCHYG00000015471
Gene Symbol: -
Cross references: -
225 Possible Orthologues:

Ensembl ID : ENSCHYG00000015336
Gene Symbol: -
Cross references: -
274 Possible Orthologues:

Ensembl ID : ENSCHYG00000015502
Gene Symbol: -
Cross references: -
148 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).